Scholars Central

Research articlePublished 12 Mar 2018

Alternative Antimicrobials for Treating Infections Caused by Drug-Resistant Uropathogens: An In vitro Laboratory-Based and Analytical Interpretation

Authors: Abdulrahman M. Alwahhabi, Khalid M. Alqahtani, Saeed A Asiri, Mohammed S. Alqarni, Abdulmajeed R Alnaish, Abdulrahman M ALqahtani, Hussain S Alqahtani, Ali M Alqahtani, Mohamed E. Hamid

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objectives: To determine the overall in vitro resistant rates among common uropathogens in order to indicate alternative antimicrobials for consideration in the future treatment of urinary tract infection (UTI). Materials and methods: Data included in this study were derived from 4 years (2013-2016) cross-sectional, a retrospective study carried out in Aseer Central Hospital, Saudi Arabia. Culture positives urine and other UT specimens (n=47193) obtained from patients suspected of having UTIs were identified and tested for antimicrobial assay using the VITEK 2 system. The analysis was done using SPSS software on culture positive samples against 39 antimicrobial agents and combinations of more than one agent. Results: Of the 47193 culture positive uropathogens, 51.5% were resistant to the 39 agents, whereas 48.5% were sensitive (p=0.7969). Antimicrobials with high sensitivity to all uropathogens were linezolid (99.1%), daptomycin (98.3%), vancomycin (86.7%), ertapenem (86.3%), teicoplanin (85.5%), tigecycline (85.3%), imipenem (82.4%), meropenem (79.6%), piperacillin/tazobactam (78.6%), and colistin (76.2%). In contrast, antimicrobials with high resistance were cephalothin (91.0%), nalidixic acid (86.7%), cefuroxime (79.6%), cefazolin (76.3%), mezlocillin (76.1%), piperacillin (73.6%), ceftriaxone (72.9%), norfloxacin (72.8%), ciprofloxacin (71.7%), and cefotaxime (69.7%). Conclusions: Empirically prescribed antimicrobials have displayed remarkable resistance in this survey. Information on the local antimicrobial trends is needed to plan evidence-based recommendations. Drugs such as linezolid, daptomycin, vancomycin, ertapenem, teicoplanin and tigecycline indicated good alternatives (≥ 85% sensitivity) for consideration in empirical UTI therapy. However, cephalothin, nalidixic acid, and cefuroxime revealed high resistance rates (≥ 80%).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Medical Research & Health Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Medical Research & Health Sciences
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Abdulrahman M. Alwahhabi”
  • BylineArticles whose byline prints “Khalid M. Alqahtani”
  • BylineArticles whose byline prints “Saeed A Asiri”
  • BylineArticles whose byline prints “Mohammed S. Alqarni”
  • BylineArticles whose byline prints “Abdulmajeed R Alnaish”
  • BylineArticles whose byline prints “Abdulrahman M ALqahtani”
  • BylineArticles whose byline prints “Hussain S Alqahtani”
  • BylineArticles whose byline prints “Ali M Alqahtani”